2. Academic Validation
  3. Suppression of insulin feedback enhances the efficacy of PI3K inhibitors

Suppression of insulin feedback enhances the efficacy of PI3K inhibitors

  • Nature. 2018 Aug;560(7719):499-503. doi: 10.1038/s41586-018-0343-4.
Benjamin D Hopkins 1,  Chantal Pauli 2 3,  Xing Du 4,  Diana G Wang 1 5,  Xiang Li 6,  David Wu 1,  Solomon C Amadiume 1,  Marcus D Goncalves 1 7,  Cindy Hodakoski 1,  Mark R Lundquist 1,  Rohan Bareja 1 3 8,  Yan Ma 4,  Emily M Harris 4,  Andrea Sboner 1 3 8 9,  Himisha Beltran 1 3 10,  Mark A Rubin 3 11,  Siddhartha Mukherjee 12,  Lewis C Cantley 13
Affiliations

Affiliations

  • 1 Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • 2 Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • 3 Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital, New York, NY, USA.
  • 4 Department of Medicine, Division of Hematology and Oncology, Columbia University Medical Center and New York Presbyterian Hospital, New York, NY, USA.
  • 5 Weill Cornell Medicine/Rockefeller University/Sloan Kettering Tri-Institutional MD-PhD Program, New York, NY, USA.
  • 6 Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.
  • 7 Division of Endocrinology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
  • 8 Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
  • 9 Department of Pathology, Weill Cornell Medicine, New York, NY, USA.
  • 10 Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
  • 11 Department of Biomedical Research and the Center for Precision Medicine, University of Bern and the Inselspital, Bern, Switzerland.
  • 12 Department of Medicine, Division of Hematology and Oncology, Columbia University Medical Center and New York Presbyterian Hospital, New York, NY, USA. sm3252@cumc.columbia.edu.
  • 13 Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA. lcantley@med.cornell.edu.
PMID: 30051890 DOI: 10.1038/s41586-018-0343-4
Abstract

Mutations in PIK3CA, which encodes the p110α subunit of the insulin-activated phosphatidylinositol-3 kinase (PI3K), and loss of function mutations in PTEN, which encodes a Phosphatase that degrades the phosphoinositide lipids generated by PI3K, are among the most frequent events in human cancers1,2. However, pharmacological inhibition of PI3K has resulted in variable clinical responses, raising the possibility of an inherent mechanism of resistance to treatment. As p110α mediates virtually all cellular responses to Insulin, targeted inhibition of this Enzyme disrupts glucose metabolism in multiple tissues. For example, blocking Insulin signalling promotes glycogen breakdown in the liver and prevents glucose uptake in the skeletal muscle and adipose tissue, resulting in transient hyperglycaemia within a few hours of PI3K inhibition. The effect is usually transient because compensatory Insulin release from the pancreas (Insulin feedback) restores normal glucose homeostasis3. However, the hyperglycaemia may be exacerbated or prolonged in patients with any degree of Insulin resistance and, in these cases, necessitates discontinuation of therapy3-6. We hypothesized that Insulin feedback induced by PI3K inhibitors may reactivate the PI3K-mTOR signalling axis in tumours, thereby compromising treatment effectiveness7,8. Here we show, in several model tumours in mice, that systemic glucose-insulin feedback caused by targeted inhibition of this pathway is sufficient to activate PI3K signalling, even in the presence of PI3K inhibitors. This Insulin feedback can be prevented using dietary or pharmaceutical approaches, which greatly enhance the efficacy/toxicity ratios of PI3K inhibitors. These findings have direct clinical implications for the multiple p110α inhibitors that are in clinical trials and provide a way to increase treatment efficacy for patients with many types of tumour.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z